Results 181 to 190 of about 64,892 (357)

Intravenous Immunoglobulin Treatment Successfully Improved Subacute Progressive Polyradiculoneuropathy with Polyclonal Gammopathy

, 2009
Kaoru Endo, Naoki Suzuki, Taro Ikenishi, Masashi Aoki, Yasuto Itoyama   +4 more
openalex   +2 more sources

Fixed‐Duration Subcutaneous Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma: Pivotal Phase 2 Primary Analysis

American Journal of Hematology, EarlyView.
ABSTRACT Mosunetuzumab is approved as an intravenous (IV) formulation for relapsed/refractory (R/R) follicular lymphoma (FL) after ≥ 2 prior therapies. A subcutaneous (SC) formulation, aiming to improve patient safety and convenience, has been developed.
Nancy L. Bartlett, Laurie H. Sehn, Sarit Assouline, Pratyush Giri, John Kuruvilla, Stephen J. Schuster, Sung‐Soo Yoon, Keith Fay, Georg Hess, Martin Dreyling, Norma C. Gutierrez, Eva Cybulski, Fidelis Sabalvaro, Elicia Penuel, Vanda Teodoro, Samuel Tracy, Denison Kuruvilla, Joseph Chen, Volker Wiebking, Michael C. Wei, L. Elizabeth Budde   +20 more
wiley   +1 more source

Antibody Assay and Anti-Inflammatory Function Evaluation of Therapeutic Potential of Different Intravenous Immunoglobulins for Alzheimer's Disease. [PDF]

Int J Mol Sci, 2023
Fei Z, Pei R, Pan B, Ye S, Zhang R, Ma L, Wang Z, Li C, Du X, Cao H.   +9 more
europepmc   +1 more source

Switch from intravenous to subcutaneous immunoglobulin in CIDP and MMN: improved tolerability and patient satisfaction

, 2014
Robert D. M. Hadden, Fabrizio Marreno
openalex   +2 more sources

Severe Occupational Hypersensitivity Pneumonitis: A Case Series of Four Patients Requiring Lung Transplantation

American Journal of Industrial Medicine, EarlyView.
ABSTRACT Hypersensitivity pneumonitis (HP) is an immune‐mediated interstitial lung disease triggered by repeated inhalation of organic or chemical antigens. Occupational exposures account for approximately 19% of all cases. Early diagnosis, identification of the responsible antigen(s), and immediate avoidance of exposure are crucial to prevent ...
Ludwig Frei‐Stuber, Judith Mohren, Ester Mau, Bernhard Werner, Rudolf A. Hatz, Jürgen Barton, Dennis Nowak   +6 more
wiley   +1 more source

Successful Use of Intravenous Immunoglobulins in an Obinutuzumab-related Acute Thrombocytopenia. [PDF]

Hemasphere, 2022
Haage TR, Surov A, Mougiakakos D, Berisha M.   +3 more
europepmc   +1 more source

Rituximab combined with intravenous immunoglobulin in autoimmune diseases: a systematic review [PDF]

Jozélio Freire de Carvalho, Thelma Larocca Skare   +1 more
openalex   +1 more source

High Dose Intravenous Immunoglobulin Does Not Affect Complement-Bacteria Interactions [PDF]

, 1998
Éric Wagner, Jeffrey L. Platt, Michael M. Frank   +2 more
openalex   +1 more source

Myelitis‐Predominant Aggressive Phenotype: Unveiling Unique Patterns of Late‐Onset Neuromyelitis Optica Spectrum Disorders

Annals of Neurology, EarlyView.
Objective The objective of this study was to compare clinical features and prognosis of late‐onset neuromyelitis optica spectrum disorder (LO‐NMOSD, onset age ≥60 years) with adult‐onset NMOSD (AO‐NMOSD, onset age 18–59 years), and to provide insights for individualized management in elderly patients.
Ya‐Lan Pu, Jin‐Zhou Feng, Hua‐Xing Meng, Hai‐Bing Xiao, Xiao‐Ling Li, Jin Zhen, Wen‐Ying Lu, Xu‐Ming Xi, Ti Wu, Bao‐Shi Yuan, Mo‐Li Fan, Chao Zhang, De‐Cai Tian, Xia Meng, Fu‐Dong Shi, Tian Song   +15 more
wiley   +1 more source

Clindamycin and intravenous immunoglobulins in pediatric invasive group A streptococcal disease: what is the evidence? [PDF]

Eur J Pediatr
van Kempen EB, Malmgren A, Elfving K, Cohen JF, Borensztajn DM.   +4 more
europepmc   +1 more source